<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "panitumumab inj VIAL">
<dose><value>6</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>20 mg/mL</value>
</strength>
<frequency><value>EVERY 2 WEEKS</value>
</frequency>
<instruction></instruction>
<volume><value>5 mL</value>
</volume>
<units><value>mg/kg</value>
</units>
<Population><value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Metastatic Colorectal Cancer. Doses less than or equal to 1000mg diluted in 100 mL 0.9% sodium chloride and administered over 60 minutes. If tolerated, subsequent doses may be administered over 30 minutes. Doses greater than 1000 mg diluted in 150 mL 0.9% sodium chloride and administered over 90 minutes.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3434</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary.</value>
</AHSFormularyStatus>
<AHFSName><value>Antineoplastic Agents</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>